VenoStent

About VenoStent

VenoStent is a company focused on improving vascular surgery outcomes, starting with renal dialysis access. Their mission is to enhance the lives of vascular surgery patients through novel tissue engineering technology.

Products & Services

SelfWrap:A bioabsorbable, flexible vascular wrap designed to reduce dialysis access site failures.

Specialties

Biomedical Engineering Materials Engineering Medical 3D Printing Tissue Engineering Technology Vascular Surgery Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 20000000 MR: - FA: 20 million FAN: 20000000	D: 2024-06-27 FD: 2024-06-27	3 investors

Series A Latest

2024-06-27

$20.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tim Boire

CEO & Co-founder

G

Geoff Lucks

COO & Co-founder

P

Pamela Misajon

Chief Compliance Officer

M

Mark Barakat

Director of Clinical Affairs

T

Tina McArthur

Vice President of Research and Engineering

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

VenoStent Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised